EFFICACY OF TANNACOMP IN IRRITABLE BOWEL SYNDROME (RANDOMIZED CONTROLLED TRIAL)
Keywords:
IBS, Tannacomp, chi-square test, relative risk, odds ratio, 95% confidence intervalAbstract
Objective: to evaluate the efficacy of Tannacomp in IBS patients compared with standard symptomatic therapy. A full statistical block (chi-square, RR, OR, 95% CI) was performed. Significant reduction of abdominal pain and diarrhea persistence was demonstrated.References
Drossman D.A. Functional gastrointestinal disorders: Rome IV // Gastroenterology. 2016. Vol. 150, № 6. P. 1257–1261.
Ford A.C., Lacy B.E., Talley N.J. Irritable bowel syndrome // Lancet. 2020. Vol. 396, № 10263. P. 1675–1688.
Camilleri M. Management of irritable bowel syndrome // N Engl J Med. 2021. Vol. 384, № 18. P. 1750–1761.
Lacy B.E., Pimentel M., Brenner D.M. ACG clinical guideline: management of irritable bowel syndrome // Am J Gastroenterol. 2021. Vol. 116, № 1. P. 17–44.
Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: a clinical review // JAMA. 2015. Vol. 313, № 9. P. 949–958.
Enck P., Aziz Q., Barbara G. et al. Irritable bowel syndrome // Nat Rev Dis Primers. 2016. Vol. 2. Article 16014.
Black C.J., Ford A.C. Global burden of irritable bowel syndrome // Nat Rev Gastroenterol Hepatol. 2020. Vol. 17, № 8. P. 473–484.
Mayer E.A., Tillisch K., Gupta A. Gut/brain axis and the microbiota // Gastroenterology. 2015. Vol. 148, № 6. P. 1262–1273.
Sperber A.D., Dumitrascu D., Fukudo S. et al. The global prevalence of IBS // Gastroenterology. 2017. Vol. 152, № 5. P. S1–S2.
Tack J., Fried M., Houghton L.A., Spicak J., Fisher G. Systematic review: the efficacy of treatments in IBS // Gut. 2018. Vol. 67, № 2. P. 160–171.
Moayyedi P., Quigley E.M.M., Lacy B.E. et al. The effect of diet in IBS: a review // Gut. 2019. Vol. 68, № 7. P. 1212–1221.
Barbara G., Grover M., Bercik P. et al. Rome Foundation working team report on IBS // Gastroenterology. 2019. Vol. 156, № 1. P. 114–127.
Simrén M., Tack J. New treatments and emerging concepts for IBS // Nat Rev Gastroenterol Hepatol. 2018. Vol. 15, № 5. P. 273–284.
Oka P., Parr H., Barberio B. et al. Global prevalence of IBS by Rome criteria: meta-analysis // Lancet Gastroenterol Hepatol. 2020. Vol. 5, № 10. P. 908–917.
Palsson O.S., Whitehead W.E., van Tilburg M.A.L. et al. Development and validation of the Rome IV diagnostic questionnaire // Gastroenterology. 2016. Vol. 150, № 6. P. 1481–1491.
